Association of statin use with clinicopathologic characteristics of prostate cancer

被引：0
|
作者：
Kim, J. [1 ]
Song, C. [1 ]
Ahn, H. [1 ]
机构：
[1] Asan Med Ctr, Dept Urol, Seoul, South Korea
来源：
EUROPEAN UROLOGY SUPPLEMENTS | 2012年 / 11卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E265 / E265
页数：1
相关论文
共 50 条
  • [31] Does statin use affect the risk of developing prostate cancer?
    Elizabeth A Platz
    Nature Clinical Practice Urology, 2009, 6 : 70 - 71
  • [32] Postdiagnosis Statin Use and Mortality in Danish Patients With Prostate Cancer
    Larsen, Signe Benzon
    Dehlendorff, Christian
    Skriver, Charlotte
    Dalton, Susanne Oksbjerg
    Jespersen, Christina Gade
    Borre, Michael
    Brasso, Klaus
    Norgaard, Mette
    Johansen, Christoffer
    Sorensen, Henrik Toft
    Hallas, Jesper
    Friis, Soren
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (29) : 3290 - +
  • [33] The Suggested Unique Association Between the Various Statin Subgroups and Prostate Cancer
    Goldberg, Hanan
    Mohsin, Faizan K.
    Saskin, Refik
    Kulkarni, Girish S.
    Berlin, Alejandro
    Kenk, Miran
    Wallis, Christopher J. D.
    Klaassen, Zachary
    Chandrasekar, Thenappan
    Ahmad, Ardalan E.
    Sayyid, Rashid K.
    Saarela, Olli
    Penn, Linda
    Alibhai, Shabbir M. H.
    Fleshner, Neil
    EUROPEAN UROLOGY FOCUS, 2021, 7 (03): : 537 - 545
  • [34] Association of statin and nonsteroidal anti-inflammatory drug use with prostate cancer outcomes: results from CaPSURE
    Katz, Matthew S.
    Carroll, Peter R.
    Cowan, Janet E.
    Chan, June M.
    D'Amico, Anthony V.
    BJU INTERNATIONAL, 2010, 106 (05) : 627 - 632
  • [35] ASSOCIATIONS BETWEEN STATIN USE AND PROSTATE SPECIFIC ANTIGEN LEVELS AND PROSTATE CANCER DIAGNOSIS
    Breau, Rodney H.
    Sauver, Jennifer L. St.
    Crispen, Paul L.
    Jacobson, Debra
    McGree, Michaela
    Jacobsen, Steven J.
    Nehra, Ajay
    Lieber, Michael
    Karnes, Jeffrey
    JOURNAL OF UROLOGY, 2009, 181 (04): : 204 - 205
  • [36] Impact of H19 Polymorphisms on Prostate Cancer Clinicopathologic Characteristics
    Hu, Ju-Chuan
    Lin, Chia-Yen
    Wang, Shian-Shiang
    Chiu, Kun-Yuan
    Li, Jian-Ri
    Chen, Chuan-Shu
    Hung, Sheng-Chun
    Yang, Cheng-Kuang
    Ou, Yen-Chuan
    Cheng, Chen-Li
    Yang, Shun-Fa
    DIAGNOSTICS, 2020, 10 (09)
  • [37] Clinicopathologic characteristics of patients with familial prostate cancer versus sporadic cases
    Antenor, JAV
    Roehl, KA
    Rubenstein, J
    Catalona, WJ
    JOURNAL OF UROLOGY, 2004, 171 (04): : 119 - 119
  • [38] ASSOCIATION OF STATIN USE TO SERUM PROSTATE SPECIFIC ANTIGEN LEVELS IN A SCREENING POPULATION
    Akduman, Bulent
    Tandberg, Daniel J.
    O'Donnell, Colin
    Hughes, Alexa
    Moyad, Mark A.
    Crawford, E. David
    JOURNAL OF UROLOGY, 2010, 183 (04): : E715 - E716
  • [39] No Association between Statin Use and Pancreatic Cancer Risk in Taiwan
    Lai, Shih-Wei
    Liao, Kuan-Fu
    Muo, Chih-Hsin
    Hsieh, Dennis Paul Hsientang
    KUWAIT MEDICAL JOURNAL, 2013, 45 (03): : 251 - 252
  • [40] Statin use and time to progression in men on active surveillance for prostate cancer
    Jayalath, Viranda H.
    Nayan, Madhur
    Finelli, Antonio
    Komisarenki, Maria
    Timilshina, Narhari
    Kulkarni, Girish S.
    Fleshner, Neil E.
    Bhindi, Bimal
    Evans, Andrew
    Zlotta, Alexandre R.
    Hamilton, Robert J.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2018, 21 (04) : 509 - 515
12345